Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

A collaborative paper from the De Val and Smart Groups has established multiple regulatory pathways responsible for the formation of blood vessels in the developing heart. In doing so they have identified a crucial pathway that is repressed in the adult heart after injury, which may hold the key to a new and improved strategy for repair.

Enhancer analysis tracks the formation of the coronary arteries during development

The growth of new blood vessels is crucially important for the repair of heart muscle after a heart attack. However, the adult heart is not capable of growing enough of the correct type of blood vessels after injury, which contributes to the damage sustained.

The reactivation of developmental pathways in the diseased heart is a long-term aim for cardiac regenerative medicine. However, the signalling and transcriptional pathways involved in coronary vessel development are not yet understood. It is also still unclear whether the processes regulating embryonic and neonatal coronary vessel growth in the healthy heart play any role during adult coronary vascular regeneration after damage.

In a paper published in Nature Communications, led by Associate Professors Sarah De Val and Nicola Smart and first authored by Dr Sophie Payne, the research team have used a novel enhancer-led approach to identify the transcriptional pathways involved in the development of coronary vessels in the healthy heart. Their technique has allowed direct interrogation of the behaviour of these pathways after ischemic injury in both the regenerative neonatal heart and the non-regenerative adult heart. 

They have identified three different regulatory pathways in mice which direct the formation of blood vessels in the heart during development. Of these, the main pathway responsible for the formation of new blood vessels, the angiogenesis-associated VEGFA-MEF2 pathway, is active in the healthy adult heart but is repressed after heart injury.

 

The adult heart doesn't respond "appropriately" to myocardial infarction to repair its coronary vasculature using the pathways used in the embryo to build the vasculature, which are activated in the more regenerative neonatal heart following injury. With this insight, we're in a better position to start investigating why and how to target a more efficient repair
- Prof Smart

The hypothesis is that the blood vessels do not grow well enough to repair the damaged heart because the heart appears to be inhibiting the pathway that it most needs to be active in order to successfully heal. Their results suggest that reactivating this pathway may improve blood vessel growth after heart attack. They will use a recently awarded grant from the British Heart Foundation to determine if this is correct.

 

This paper identifies novel regulators of coronary vessel growth and reveals unsuspected variations in the mechanisms regulating coronary vessel growth depending on developmental stage and disease state, observations with significant implications to future strategies for cardiac regeneration. It also identifies a novel, druggable target for therapeutic manipulations of vascular growth in the adult ischemic heart. - Prof De Val

The full paper "Regulatory pathways governing murine coronary vessel formation are dysregulated in the injured adult heart" is available to read in Nature Communications.

Similar stories

Key cause of type 2 diabetes uncovered

Research led by Dr Elizabeth Haythorne and Professor Frances Ashcroft reveals high blood glucose reprograms the metabolism of pancreatic beta-cells in diabetes. They have discovered that glucose metabolites, rather than glucose itself, are key to the progression of type 2 diabetes. Glucose metabolites damage pancreatic beta-cell function, so they are unable to release enough of the hormone insulin. Reducing the rate at which glucose is metabolised, and these glucose metabolites build up, can prevent the effects of hyperglycaemia.

New study shows clinical symptoms for Alzheimer’s can be predicted in preclinical models

Establishing preclinical models of Alzheimer’s that reflect in-life clinical symptoms of each individual is a critically important goal, yet so far it has not been fully realised. A new collaborative study from the University of Oxford has demonstrated that clinical vulnerability to an abnormally abundant protein in Alzheimer’s brain is in fact reflected in individual patient induced pluripotent stem cell-derived cortical neurons.

Updating the circuit maps of the sympathetic neural network

A new review from Professor Ana Domingos’ lab and colleagues offers a fresh modern viewpoint on sympathetic neurons and their relation to immune cells and obesity.

New Pfizer grant paves the way to a better understanding of how body fat is controlled

Professor Ana Domingos has been awarded a highly competitive independent research grant from Pfizer to discover ‘the role of Sympathetic-associated Perineurial barrier Cells in obesity’.

Collaborative MRC grant paves the way to new therapeutic targets for stress and anxiety disorders

Dr Armin Lak, Associate Professor Ed Mann and Professor Zoltán Molnár have been awarded a £733K Project Grant from the Medical Research Council on “Orexinergic projections to neocortex: potential role in arousal, stress and anxiety-related disorders”.